JERUSALEM, Israel, March 27 /PRNewswire-FirstCall/ -- IDenta Corp. today announced the name of the law firm that will immediately begin representing the company’s strategic agenda with the U.S. government. Venable LLC, a top U.S. law firm based in Washington D.C., has signed an agreement to represent IDenta’s lobbying interests with numerous governmental agencies including the U.S. Department of Homeland Security.
“I want to thank the principles of Venable for considering IDenta Corporation and our product line worthy of their representation,” remarked Yaacov Shoham, Identa President and CEO. “They immediately had a clear grasp of the crucial role that infallible drug identification plays in the war against drugs, and how our patented detection process sets IDenta apart from all other products in the field.”
IDenta’s Stinger product line, developed for professional use, and IDenta’s Confirm product line, developed for retail distribution, each incorporate a very easy-to-use, self-contained packaging process which virtually protects against false positives. The U.S. marketplace for professional and consumer drug detection products is estimated to be well over $100 million dollars per year.
About Venable LLP
As one of The American Lawyer’s top 100 law firms, Venable LLP employs a diverse staff of lawyers practicing in all areas of corporate and business law, complex litigation, intellectual property and government affairs. Venable serves corporate, institutional, governmental, nonprofit and individual clients throughout the U.S. and around the world from its headquarters in Washington, D.C. and offices in Maryland, New York and Virginia. For more information, visit www.venable.com
About IDenta
IDenta Corporation is a leading developer of proprietary on-site drug detection kits used by governments and security forces around the world. Information concerning IDenta’s business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at www.IDenta.biz and www.drugsdetector.com
IDenta proudly supports “D.A.M.M.A.D.D.,” Dads and Mad Moms Against Drug Dealers, (www.dammadd.org)
For Investor Relations, lobbying interests or information concerning IDenta’s products internationally contact:
Yaacov Shoham, IDenta Corp., CEO Tel: +972-52-6554487, +972-8-9716874 Fax: +972-8-9716875 fpi@drugsdetector.com For Investor Relations in the United States contact: Randy Jacobs, SITCOM LLC +1-800-316-9437 rjacobs@nvest.us
Certain of the statements contained herein may be, within the meaning of the federal securities laws, “forward-looking statements” that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management’s expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
IDenta Corp.
CONTACT: For Investor Relations, lobbying interests or informationconcerning IDenta’s products internationally contact: Yaacov Shoham, IDentaCorp., CEO, Tel: +972-52-6554487, +972-8-9716874, Fax: +972-8-9716875,fpi@drugsdetector.com; For Investor Relations in the United States contact:Randy Jacobs, SITCOM LLC, +1-800-316-9437, rjacobs@nvest.us
